Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2026)

Camp4 Therapeutics has reported Total Liabilities for 4 years, with the latest figure at $74.6 million in Q1 2026.

• Quarterly Total Liabilities rose 565.61% year-over-year to $74.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.6 million (up 565.61% YoY) and the FY2025 annual result came in at $70.1 million, up 362.34% from the prior year.
• Total Liabilities advanced to $74.6 million in Q1 2026 per CAMP's latest filing, from $70.1 million in the prior quarter.
• Over five years, Total Liabilities peaked at $74.6 million in Q1 2026 and troughed at $11.2 million in Q1 2025.
• A 4-year average of $30.6 million and a median of $17.4 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2024 and 2026: Total Liabilities slipped 8.26% in 2024, then jumped 565.61% in 2026.
• Over 4 years, Total Liabilities stood at $16.5 million in 2023, then declined by 8.26% to $15.2 million in 2024, then surged by 362.34% to $70.1 million in 2025, then advanced by 6.35% to $74.6 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $74.6 million, $70.1 million, and $27.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.